We invest in traditional insurance, distribution and Insurtech. We also love SAAS solutions that may look to sell into insurance carriers or sell adjacent to insurance products.
We invest globally in pioneering companies in genomics and precision health, in markets such as life science tools, clinical diagnostics, therapeutics, digital health, and other areas impacted by genomics.
We invest in seed stage FinTech companies across North America, and have been doing so since 2013. We focus on founders who are driven on changing how financial services are provided to a large market.
We only invest in 2-3 opportunities per year and thus take a hands-on approach with our founders. We are lead investors and will write checks that complete a large portion of a round.
We invest in technology solutions aiming to address complex geopolitical challenges.
Free/open-source technology and safety infrastructure, including content-moderation tools, DDoS protection, encrypted networking frameworks, and publicly available developer resources.